Back To Work
Today is my first day back to work since I left to begin a clinical trial at MD Anderson on January 16th. To summarize the past three and a half months, I experienced an increase in toxicity during the first trial for a t315i leukemia mutation, fought through muscle weakness and nausea, lost some of […]